Blue Horseshoe Stocks: LULU Recap & Other Winning Calls

Lulu Lemon Athletica, Inc. LULU

First on our docket this morning is to provide a rundown of the excellent single-session gains afforded to us by our options trading idea in yesterday morning’s premarket report.

We signaled a range of contracts that we felt had a reasonable chance of success given its conditions leading up to the opening bell, and each of the seven contracts contained in our observed range of LULU Weekly $67-70 Calls.
yielded prime chances for quick-strike profits.

$67 Calls – Trading Range: 1.70-4.65 – Max Gain: 174%
$67.50 Calls – Trading Range: 1.41-4.45 – Max Gain: 215%
$68 Calls– Trading Range: .89-3.87 – Max Gain: 335%
$68.50 Calls – Trading Range: .79-3.22 – Max Gain: 308%
$69 Calls – Trading Range: .75-2.85 – Max Gain: 280%
$69.50 Calls– Trading Range: .56-2.56 – Max Gain: 357%
$70 Calls– Trading Range: .37-2.11 – Max Gain: 470%


Yesterday’s Other Winners

Also included in yesterday’s premarket report were a couple of plays on the stock side of things that turned out to be significant intraday runners themselves.

General Cannabis Corp. CANN – The cannabis space has been a bit touch-and-go in recent months, but we have not let that stop us from routinely scanning for opportunities in the sector, and that’s just what we found yesterday in CANN.

We watched as the stock traded up from a daily low of .73 only to hit a subsequent high of 1.22. That went down in the books as an intraday pop of 67% It was followed by a dip-and-rip that carried it on a second run from .7375-1.08 (+46%).
______

Mountain High Acquisitions Corp. MYHI –  This is another cannabis related play that also enjoyed an appreciable move-up yesterday following our morning tag as a bottom-bouncer. MYHI traded in a range from .0235-.034, for a respectable 45% run on the day.

We’ll continue to track this along with the above mentioned play for further opportunities as we head into week’s end. Both have exhibited the type of volatility that can make for more quick in-and-out gains.


Adaptive Medias , Inc. ADTM

Lastly, we want to draw attention back to ADTM, which we we reminded our readers at the beginning of the week, was just coming off of its recently-registered annual low. It has since provided us with not one but two significant chances. On

Tuesday the stock ran from a low of .0027 right out of the starting gate to a high of .0044 shortly after 11am, for gains of up to 63%  Yesterday the action provided us with a follow-up chance, as ADTM traded in a range from .003-.004- a 33% pop. That came along with a strong close at .0038 as well as twice the average 30-day volume, so we’ll definitely be watching for ADTM to record higher highs and higher lows in sessions to come.


Extended Watchlist:
CERE, RADA, CLMT, TPLM, LOGG

Blue Horseshoe Stocks: JNUG, RAMO & More

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

We’ve been tracking JNUG in the wake of last week’s annual low on the price of gold, and as the price of the precious metal has rebounded it has provided us with a few swing-trade opportunities.

Initially we saw JNUG run from 3.59-4.44 (+24%), and after pulling back slightly to 3.65 yesterday morning, the ETF ran back to 4.40, an intraday increase of 20% on several times the average trading volume.

We expect to witness similar patterns of activity in JNUG as long as the price of gold continues to rebound. We’re looking for it to hold support at or above $1161 (Trading in $1166-range this morning)


Ramoil Management Ltd. RAMO

We want to tag RAMO this morning and add it to our list of cannabis-related stocks; according to a PR we just caught coming over the wires, the company is set to begin clinical testing with both CBD and THC (chemical compounds found in marijuana).

It is conveniently timed with the “major hurdle” that was just cleared with regard to government approval of using cannabis for the treatment of soldiers diagnosed with PTSD. The U.S. Department of Health & Human Services has given its stamp of approval, with the measure only needing DEA clearance before becoming policy. >> Read Article in US Today

LAS VEGAS, Nov. 12, 2014 /PRNewswire/ — RAMOIL MANAGEMENT, Ltd (RAMO) wants to honor and support our veterans by announcing that RAMO Bio-Med, Inc., its wholly owned subsidiary, is beginning with controlled clinical testing of “RAMO CBD” and “RAMO THC” formulas for the treatment of Post Traumatic Stress Disorder, commonly known as PTSD. >> Full PR


Dendreon Corp. DNDN

We’ve been watching DNDN for a bounce opportunity this week, as the stock has been way oversold of late. This morning it appears as if the stock is trying to gap up slightly, so we just want to throw in a reminder that this stock could turn into a hefty bounceplay at any time.


Extended Watchlist:
SWET(News), GEVO, RADA, SUPN, SUSQ, CGG

Get Our FREE Daily Reports!